CD8A and myeloid sarcoma: When using the CD4/CD8 ratio regarding histopathological findings, the results of this study pointed to the efficiency of WJ-MSCs in modulating the response of animals in the EAE model, which contributes to the study of this cell type and its subpopulations as adjunct therapies in the treatment of MS.